| Ticker | TNYA |
|---|---|
| ISIN | US87990A1060 |
| Sector | Tecnología |
| Mercado | NASDAQ |
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor ...
Tenaya Therapeutics, Inc opera en el sector Healthcare, industria Biotechnology.